These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23949225)

  • 1. Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4.
    Lu H; Sun J; Wang F; Feng L; Ma Y; Shen Q; Jiang Z; Sun X; Wang X; Jin H
    Cell Death Dis; 2013 Aug; 4(8):e776. PubMed ID: 23949225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling.
    Lu H; Jin W; Sun J; Feng L; Lan H; Shen Q; Ma Y; Li J; Yue Y; Jin H; Wang X
    FEBS Lett; 2014 Sep; 588(18):3322-6. PubMed ID: 25064842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes
    Byun HJ; Yoon JH; Lee SK
    Yonsei Med J; 2020 Nov; 61(11):923-934. PubMed ID: 33107235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells.
    Fujii S; Ochiai A
    Cancer Sci; 2008 Apr; 99(4):738-46. PubMed ID: 18377425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2.
    You BH; Yoon JH; Kang H; Lee EK; Lee SK; Nam JW
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24620-24629. PubMed ID: 31732666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways.
    Liu L; Xiao B; Hirukawa A; Smith HW; Zuo D; Sanguin-Gendreau V; McCaffrey L; Nam AJ; Muller WJ
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2303010120. PubMed ID: 37549258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer.
    Ren L; Deng H; Jiang Y; Liu C
    Dig Dis Sci; 2023 Apr; 68(4):1292-1305. PubMed ID: 36877334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway.
    Li P; Ge D; Li P; Hu F; Chu J; Chen X; Song W; Wang A; Tian G; Gu X
    J Cell Mol Med; 2020 Sep; 24(17):10151-10165. PubMed ID: 32715641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway.
    Fu Y; Wang Z; Luo C; Wang Y; Wang Y; Zhong X; Zheng H
    Transl Oncol; 2020 Feb; 13(2):423-440. PubMed ID: 31911277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
    Fu HL; Ma Y; Lu LG; Hou P; Li BJ; Jin WL; Cui DX
    J Biomed Nanotechnol; 2014 Jul; 10(7):1217-30. PubMed ID: 24804542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
    FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
    Chen DL; Zhang DS; Lu YX; Chen LZ; Zeng ZL; He MM; Wang FH; Li YH; Zhang HZ; Pelicano H; Zhang W; Xu RH
    Oncotarget; 2015 May; 6(13):10868-79. PubMed ID: 25869101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.
    Shi B; Liang J; Yang X; Wang Y; Zhao Y; Wu H; Sun L; Zhang Y; Chen Y; Li R; Zhang Y; Hong M; Shang Y
    Mol Cell Biol; 2007 Jul; 27(14):5105-19. PubMed ID: 17502350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
    Li H; Cai Q; Godwin AK; Zhang R
    Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.
    Matsukawa Y; Semba S; Kato H; Ito A; Yanagihara K; Yokozaki H
    Cancer Sci; 2006 Jun; 97(6):484-91. PubMed ID: 16734726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.